Chemical Peel Boca Raton: Depth, Skin Type and What Is Actually Regulated

A chemical peel Boca Raton clinics offer can mean anything from a lunchtime exfoliation to a procedure that injures skin down to the mid-dermis. They share a name and very little else. Knowing which depth you are being offered, and what the controlled trials show at that depth for your skin, is the whole of an informed decision.

The three depths, and which agents reach them

Depth is the single most useful concept in this category, because it predicts the result, the recovery and the risk better than the brand name on the bottle.

Depth is judged during treatment by frosting. Level I is “erythema with a stringy or patchy light frosting.” Level II is “uniform, white-coated frosting with underlying erythema showing through.” Level III is “solid white enamel frosting with little to no background erythema” and indicates penetration to the papillary dermis. Watching frosting rather than the clock is how depth is actually controlled.

What the controlled trials actually found

The most directly relevant trial for a South Florida patient population compared three superficial peels in Fitzpatrick IV to VI: 45 patients, fifteen per group, six sessions fortnightly over twelve weeks.

Active acne scores fell by 70.55% with 35% glycolic acid, 74.14% with 20% salicylic–10% mandelic, and 69.7% with phytic acid. On post-acne pigmentation the salicylic–mandelic combination was clearly strongest, taking the index from 10.13 to 2.8 against 10.87 to 6.2 for glycolic, a difference that reached significance. Adverse events were minor: two patients in each of two groups reported burning, one reported erythema that settled in two days, none developed post-inflammatory hyperpigmentation, and nobody discontinued.

For melasma the picture is more sobering, and worth knowing before you commit to a course. A retrospective review of 40 melasma patients, 82.5% of them Fitzpatrick V or VI, escalated glycolic acid 20–40% then TCA 15–40% over twenty weeks alongside nightly hydroquinone and daily SPF 50. Severity improved significantly from baseline to three months — and then stopped. Baseline to six months was not statistically significant, and the TCA phase added no measurable benefit over the glycolic phase, while pain rose from 3.88 to 6.4 out of 10 and pigmentation changes rose from 12.5% to 32.5%.

What recovery looks like, and who is at higher risk

The standard review of medium and deep peel complications is largely qualitative, and that is itself worth reporting, because peel content online routinely quotes complication percentages that have no source. Apart from the phenol arrhythmia figure, that review gives no rates.

What it does establish is the shape of the risk. Post-inflammatory hyperpigmentation is “the most common complication of TCA peeling,” with skin types III to VI at higher risk. Persistent erythema runs three to five days after a superficial peel, fifteen to thirty after a medium one, and sixty to ninety after a deep one. Hypertrophic scarring from medium-depth peels is described as rare, with TCA more likely to scar than other agents, and the jawline and perioral area at greater risk. Herpes reactivation is preventable with prophylaxis. And the summarising sentence: “complications are also more likely with darker skin types, certain peeling agents, and sun exposure.”

Set against that, the controlled data in darker skin are genuinely reassuring on the outcome everyone fears most. Across both trials above, in patients who were overwhelmingly Fitzpatrick IV to VI, scarring was recorded in none of them — zero of forty in the melasma study despite high concentrations, and no discontinuations in the acne study. Pigmentation change was temporary and resolved within two to four weeks.

The agent gradient is the practical lesson: in Fitzpatrick IV to VI, TCA produced pigmentation change in 32.5% against 12.5% for glycolic. Choosing the gentler agent and priming the skin beforehand is not timidity, it is what the data support.

What is regulated, and what “medical grade” really means

There is no FDA clearance to cite for a peel and no approval to claim. The FDA states plainly that it does not approve cosmetics. What exists instead is a line between cosmetic and drug: products intended “for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, or to affect the structure or any function of the body are drugs under the law.” A medium or deep peel is, by design, intended to affect the structure of the skin.

The Cosmetic Ingredient Review panel’s safety conditions for alpha hydroxy acid products are worth knowing because of how far professional peels sit outside them: AHA concentration 10% or less, and a final pH of 3.5 or greater. Professional peels run 20–70% at low pH deliberately. Citing consumer-cosmetic safety limits as though they validate a professional peel gets the logic backwards.

The FDA’s own adverse-event tally is the best safety dataset in this category and is rarely mentioned: between 1992 and 2004 the agency received 114 reports of adverse reactions to AHA products — burning (45), dermatitis or rash (35), swelling (29), pigmentary changes (15), blisters or welts (14). FDA-sponsored research also found that applying AHAs increases UV sensitivity, though the effect is reversible after stopping. Hence the recommended label warning, and hence the sunscreen conversation being part of the treatment rather than an add-on.

For pigment concerns that peels are not the best answer to, the IPL photofacial page covers the light-based option, and the skin and laser section of the services page sets out the alternatives.

Frequently asked questions

Sources and how this page was built

Depth classification and complication descriptions are quoted from the clinical reviews cited. Efficacy and adverse-event figures come from the two controlled studies named, both conducted predominantly in Fitzpatrick IV to VI. The regulatory position is quoted from FDA pages on alpha and beta hydroxy acids and on what the agency does and does not approve, read 26 September 2026. Where the standard complications review gives no rate, this page says so rather than supplying one from elsewhere.

Why patients choose Brazelia MedSpa

This page tells you that stronger is not better, that melasma comes back, and that the phrase on the bottle has no regulatory meaning. None of that sells an aggressive package, and all of it is what the studies found. A clinic willing to publish the recurrence rate is a clinic that will give you a realistic plan rather than a course of six.

A chemical peel in Boca Raton is chosen here by depth and agent against your skin type, starting gentler in Fitzpatrick IV and above because that is where the controlled data point, and priming the skin beforehand because the study that recorded no scarring at all is the one that primed. Deep phenol peeling we do not offer.

Brazelia MedSpa has treated patients from the same address in downtown Boca Raton for 18 years, near Mizner Park, and serves patients across South Florida, from Delray Beach and Boynton Beach to Deerfield Beach and Fort Lauderdale. In a field where med spas open and close within a season, staying in one place that long is its own kind of evidence. Patients rate the practice 4.5 out of 5 across 24 Google reviews.

A face is also rarely treated as just a face here. Because Brazelia MedSpa runs hormone, metabolic, skin and regenerative programmes under one roof, a treatment plan can take account of what else is going on — skin quality, weight change, hormonal shifts — instead of being sold in isolation. Where that is relevant to you it comes up at the consultation. Where it is not, nobody raises it.

New patients start with a consultation, and nothing is treated on a first visit unless you want it to be. You will hear what the approved labelling actually supports before you hear what it costs.

This page describes what published labels, regulatory records and peer-reviewed research report about these treatments. It is general health information, not medical advice, and it is not a substitute for a consultation. Whether any treatment is appropriate for you is a clinical judgement that depends on your history and examination.